AU5225300A - Use of soluble protein molecules expressed by the pancreas and kidney glomerulus - Google Patents

Use of soluble protein molecules expressed by the pancreas and kidney glomerulus

Info

Publication number
AU5225300A
AU5225300A AU52253/00A AU5225300A AU5225300A AU 5225300 A AU5225300 A AU 5225300A AU 52253/00 A AU52253/00 A AU 52253/00A AU 5225300 A AU5225300 A AU 5225300A AU 5225300 A AU5225300 A AU 5225300A
Authority
AU
Australia
Prior art keywords
pancreas
soluble protein
protein molecules
molecules expressed
kidney glomerulus
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU52253/00A
Other languages
English (en)
Inventor
Harry Holthofer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of AU5225300A publication Critical patent/AU5225300A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2803—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • C07K14/70525—ICAM molecules, e.g. CD50, CD54, CD102
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Cell Biology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AU52253/00A 1999-06-15 2000-06-15 Use of soluble protein molecules expressed by the pancreas and kidney glomerulus Abandoned AU5225300A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FI991369A FI991369A0 (fi) 1999-06-15 1999-06-15 Haiman ja munuaiskeräsen ilmentäminen liukoisten proteiinimolekyylien käyttö
FI991369 1999-06-15
PCT/FI2000/000540 WO2000077044A1 (fr) 1999-06-15 2000-06-15 Utilisation de molecules proteiniques solubles exprimees par le pancreas et le glomerule de malpighi

Publications (1)

Publication Number Publication Date
AU5225300A true AU5225300A (en) 2001-01-02

Family

ID=8554889

Family Applications (1)

Application Number Title Priority Date Filing Date
AU52253/00A Abandoned AU5225300A (en) 1999-06-15 2000-06-15 Use of soluble protein molecules expressed by the pancreas and kidney glomerulus

Country Status (6)

Country Link
EP (1) EP1185556A1 (fr)
AU (1) AU5225300A (fr)
CA (1) CA2374000A1 (fr)
FI (1) FI991369A0 (fr)
HK (1) HK1044781A1 (fr)
WO (1) WO2000077044A1 (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030198959A1 (en) * 2002-03-28 2003-10-23 Kurnit David M. Methods and compositions for analysis of urine samples in the diagnosis and treatment of kidney diseases
FI20021406A0 (fi) * 2002-07-24 2002-07-24 Glomega Inc Oy Densiinitapaisten yhdisteiden käyttö
SG184571A1 (en) * 2010-04-12 2012-11-29 Univ Singapore A biomarker for renal function in patients with type 2 diabetes
JP2023546669A (ja) * 2020-10-22 2023-11-07 ザ ブリガム アンド ウィメンズ ホスピタル インコーポレイテッド 抗体媒介性後天性原発型または再発型特発性ネフローゼ症候群を同定および処置する方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6207811B1 (en) * 1998-03-18 2001-03-27 Karl Tryggvason Nephrin gene and protein

Also Published As

Publication number Publication date
WO2000077044A1 (fr) 2000-12-21
FI991369A0 (fi) 1999-06-15
EP1185556A1 (fr) 2002-03-13
HK1044781A1 (zh) 2002-11-01
CA2374000A1 (fr) 2000-12-21

Similar Documents

Publication Publication Date Title
AU2001267475A1 (en) Combinations of Enzyme Inhibitor-Containing Preparations and the use thereof
AU2001263466A1 (en) Soluble CTLA4 mutant molecules and uses thereof
AU2001238426A1 (en) Prepaints and methods of preparing paints from the prepaints
AU4189799A (en) Prostate growth-associated membrane proteins
AU2002219135A1 (en) Substituted 2-anilino-benzimidazoles and the use thereof as NHE-inhibitors
AU2002219960A1 (en) Molecules of the card-related protein family and uses thereof
AU5894900A (en) Novel molecules of the card-related protein family and uses thereof
AU4711400A (en) Lipocalin family protein
AU3931400A (en) N-benzimidazolylmethyl- and n-indolylmethyl-benzamides and their use as crf modulators
AU3749499A (en) Novel molecules of the bgckr-related protein family and uses thereof
AU5225300A (en) Use of soluble protein molecules expressed by the pancreas and kidney glomerulus
AU1238201A (en) Novel molecules and the card-related protein family and uses thereof
AU5772299A (en) Novel molecules of the tango-93-related protein family and uses thereof
AU4755600A (en) Benzohetero cyclylcyclo hexenones and their use as herbicides
AU2002358142A1 (en) Low-dust solid fuel preparations
AU2001223687A1 (en) Ball-and-socket joint
AU1657501A (en) Determining the functions and interactions of proteins by comparative analysis
AU2002362414A1 (en) Novel molecules of the hkid-1-related protein family and uses thereof
AU3512900A (en) Novel thioredoxin family active site molecules and uses therefor
AU2136401A (en) P450rai-2 and related proteins
AU3506800A (en) Leukocyte- and blood-associated proteins
AU4545299A (en) Novel molecules of the aip-related protein family and uses thereof
AU2001229697A1 (en) Novel molecules of the card-related protein family and uses thereof
AUPQ884500A0 (en) Novel therapeutic molecules and uses therefor - III
AU1243601A (en) Novel molecules of the card-related protein family and uses thereof

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase